-
Biden Says Full Approval for COVID-19 Vaccines Coming Soon
drugs
July 23, 2021
As he urged Americans who are still hesitant to get vaccinated, President Joe Biden told an Ohio town hall on Wednesday night that he expected the U.S. Food and Drug Administration would soon give final approval to COVID-19 vaccines.
-
As Olympics Begin, Tokyo Posts Highest Number of New COVID-19 Cases in Six Months
drugs
July 23, 2021
One day before the official start of the Tokyo Olympics, the city has recorded its highest number of new COVID-19 cases in six months. The 1,979 cases reported on Thursday are the most seen since 2,044 cases were recorded on Jan. 15.
-
Acticor Biotech Announces the Completion of Enrollment in its GARDEN Clinical Trial, a COVID-19-induced Acute Respiratory Distress Syndrome Efficacy Study
firstwordpharma
July 23, 2021
Acticor Biotech today announces the completion of recruitment in GARDEN, its phase 2 clinical study on the use of glenzocimab n patients with COVID-19-induced Acute Respiratory Distress Syndrome (ARDS).
-
Japan mulls asking Pfizer to speed up COVID-19 vaccine delivery
firstwordpharma
July 23, 2021
According to a government source on Thursday, Japan’s government is considering asking Pfizer to speed up its delivery of COVID-19 vaccine beyond the fall amid concern about a supply shortage, reported Kyodo News+.
-
Study By Providence Researchers Suggest Deferred Care Has Led To Higher Inpatient Mortality For Non-Covid-19 Patients
prnewswire
July 23, 2021
Providence published findings today demonstrating appreciable declines in unplanned hospitalizations along with an increase in hospital mortality for a broad mix of medical conditions during the COVID-19 pandemic.
-
Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring
prnewswire
July 23, 2021
VolitionRx Limited (NYSE AMERICAN: VNRX) cost effective blood tests to help diagnose a range of cancers and other diseases in both humans and animals, has been working with researchers at two leading NHS Foundation Trusts on two studies in COVID-19.
-
National Survey Finds Increased Interest in Competency-Based Education Amid Pandemic
prnewswire
July 23, 2021
New findings from an annual survey on competency-based education (CBE) suggests continued growth and interest in the flexible, workforce-aligned model.
-
Take your best shot: Which SARS-CoV-2 vaccine should I get, if any?
worldpharmanews
July 22, 2021
Vaccine hesitancy continues to be a hurdle in the development of widespread immunity within the U.S. population as the COVID-19 pandemic enters its second year.
-
Centre allows research on AYUSH Medicines to curb COVID-19
expresspharma
July 22, 2021
States/UTs licensing authorities have been requested to expedite the process of the licensing/approval of applications for the manufacturing of AYUSH-64, Minister of State for AYUSH informed Rajya Sabha 20th.
-
Aptar CSP’s Activ-Film Technology Protects COVID-19 Tests
contractpharma
July 22, 2021
Aptar CSP Technologies announced its Activ-Film technology protects two new at-home COVID-19 tests that recently received Emergency Use Authorization (EUA) from the U.S. FDA.